Why is Nidan Laborator. falling/rising?

As of 23-Sep, Nidan Laboratories & Healthcare Ltd's stock price is currently at 19.05, reflecting a slight increase of 0.05 or 0.26%. The stock has outperformed its sector today by 0.73%, and it has shown a positive return of 1.60% over the past week, despite a significant decline of 43.05% over the past year. The stock's delivery volume has also increased by 103.13% compared to the 5-day average, indicating rising investor participation. However, the company has not declared results in the last six months, and its ability to service debt is weak, which contributes to its long-term fundamental weaknesses. The stock's return on equity is low at 6.85%, and while it has an attractive valuation with a ROCE of 3.4, the overall negative performance in profits, which have fallen by 40%, raises concerns.
In the broader market context, the stock's short-term performance of +1.60% over the past week contrasts with the benchmark Sensex, which has declined by 0.28% during the same period. However, the stock has underperformed the benchmark significantly over the longer term, with a year-to-date decline of 33.97% compared to the Sensex's gain of 6.45%. This consistent underperformance against the benchmark over the last three years, coupled with the company's weak fundamentals, suggests that while there may be short-term gains, the long-term outlook remains challenging.